{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:57:51Z","timestamp":1785229071446,"version":"3.55.0"},"reference-count":69,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,21]]},"abstract":"<jats:p>The rapid emergence of antibiotic-resistant bacterial strains has prompted efforts to find new and more efficacious treatment strategies. Targeting virulence factors produced by pathogenic bacteria has gained particular attention in the last few years. One of the inherent advantages of this approach is that it provides less selective pressure for the development of resistance mechanisms. In addition, antivirulence drugs could potentially be the answer for diseases in which the use of conventional antibiotics is counterproductive. That is the case for bacterial toxin-mediated diseases, in which the severity of the symptoms is a consequence of the exotoxins produced by the pathogen. Examples of these are haemolytic-uraemic syndrome produced by Shiga toxins, the profuse and dangerous dehydration caused by Cholera toxin or the life-threatening colitis occasioned by clostridial toxins. This review focuses on the recent advances on the development of small molecules with antitoxin activity against Enterohaemorrhagic Escherichia coli, Vibrio cholerae and Clostridium difficile given their epidemiological importance. The present work includes studies of small molecules with antitoxin properties that act directly on the toxin (direct inhibitors) or that act by preventing expression of the toxin (indirect inhibitors).<\/jats:p>","DOI":"10.1042\/etls20160013","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T13:47:23Z","timestamp":1492782443000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disarming the enemy: targeting bacterial toxins with small molecules"],"prefix":"10.1042","volume":"1","author":[{"given":"Alejandro","family":"Huerta-Uribe","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Roe","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"2021111608053614400_ETLS-2016-0013CC1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.anaerobe.2015.10.009","article-title":"Virulence factors of Clostridium difficile and their role during infection","volume":"37","author":"Janoir","year":"2016","journal-title":"Anaerobe"},{"key":"2021111608053614400_ETLS-2016-0013CC2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N. Engl J. Med."},{"key":"2021111608053614400_ETLS-2016-0013CC3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"2021111608053614400_ETLS-2016-0013CC4","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1128\/JB.00445-10","article-title":"Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production","volume":"192","author":"Merrigan","year":"2010","journal-title":"J. Bacteriol."},{"key":"2021111608053614400_ETLS-2016-0013CC5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/592257","article-title":"Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078","volume":"47","author":"Goorhuis","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"2021111608053614400_ETLS-2016-0013CC6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/toxins8050134","article-title":"Clostridium difficile toxins A and B: insights into pathogenic properties and extraintestinal effects","volume":"8","author":"Di Bella","year":"2016","journal-title":"Toxins"},{"key":"2021111608053614400_ETLS-2016-0013CC7","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.3390\/toxins7124874","article-title":"The role of Rho GTPases in toxicity of Clostridium difficile toxins","volume":"7","author":"Chen","year":"2015","journal-title":"Toxins"},{"key":"2021111608053614400_ETLS-2016-0013CC8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fcimb.2012.00028","article-title":"Toward a structural understanding of Clostridium difficile toxins A and B","volume":"2","author":"Pruitt","year":"2012","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC9","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1172\/JCI119698","article-title":"Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells","volume":"100","author":"Chaves-Olarte","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2021111608053614400_ETLS-2016-0013CC10","doi-asserted-by":"publisher","first-page":"306ra148","DOI":"10.1126\/scitranslmed.aac9103","article-title":"A small-molecule antivirulence agent for treating Clostridium difficile infection","volume":"7","author":"Bender","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"2021111608053614400_ETLS-2016-0013CC11","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1007\/s11033-014-3417-x","article-title":"Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways","volume":"41","author":"Azad","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"2021111608053614400_ETLS-2016-0013CC12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.chembiol.2014.12.010","article-title":"Small molecule inhibitors of Clostridium difficile toxin B-induced cellular damage","volume":"22","author":"Tam","year":"2015","journal-title":"Chem. Biol."},{"key":"2021111608053614400_ETLS-2016-0013CC13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4161\/gmic.26854","article-title":"Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance","volume":"5","author":"Gerding","year":"2014","journal-title":"Gut. Microbes"},{"key":"2021111608053614400_ETLS-2016-0013CC14","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1128\/AAC.04436-14","article-title":"Subinhibitory concentrations of LFF571 reduce toxin production by Clostridium difficile","volume":"59","author":"Sachdeva","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111608053614400_ETLS-2016-0013CC15","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1021\/jm201685h","article-title":"Discovery of LFF571: an investigational agent for Clostridium difficile infection","volume":"55","author":"Lamarche","year":"2012","journal-title":"J. Med. Chem."},{"key":"2021111608053614400_ETLS-2016-0013CC16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/toxins8040101","article-title":"EGA protects mammalian cells from Clostridium difficile CDT, Clostridium perfringens iota toxin and Clostridium botulinum C2 toxin","volume":"8","author":"Schnell","year":"2016","journal-title":"Toxins"},{"key":"2021111608053614400_ETLS-2016-0013CC17","doi-asserted-by":"publisher","first-page":"E4904","DOI":"10.1073\/pnas.1302334110","article-title":"Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses","volume":"110","author":"Gillespie","year":"2013","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021111608053614400_ETLS-2016-0013CC18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1574-6976.2002.tb00605.x","article-title":"Vibrio cholerae and cholera: out of the water and into the host","volume":"26","author":"Reidl","year":"2002","journal-title":"FEMS Microbiol. Rev."},{"key":"2021111608053614400_ETLS-2016-0013CC19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/MMBR.62.4.1301-1314.1998","article-title":"Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae","volume":"62","author":"Faruque","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"2021111608053614400_ETLS-2016-0013CC20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1995-7645(11)60149-1","article-title":"Cholera: a great global concern","volume":"4","author":"Mandal","year":"2011","journal-title":"Asian Pac. J. Trop. Med."},{"key":"2021111608053614400_ETLS-2016-0013CC21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJMp1013771","article-title":"Antibiotics for both moderate and severe cholera","volume":"364","author":"Nelson","year":"2011","journal-title":"N. Engl J. Med."},{"key":"2021111608053614400_ETLS-2016-0013CC22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1099\/jmm.0.023051-0","article-title":"Antibiotic resistance mechanisms of Vibrio cholerae","volume":"60","author":"Kitaoka","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC23","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/toxins2071612","article-title":"AB toxins: a paradigm switch from deadly to desirable","volume":"2","author":"Odumosu","year":"2010","journal-title":"Toxins"},{"key":"2021111608053614400_ETLS-2016-0013CC24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00018-008-7496-5","article-title":"Cholera toxin structure, gene regulation and pathophysiological and immunological aspects","volume":"65","author":"S\u00e1nchez","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"2021111608053614400_ETLS-2016-0013CC25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1743-422X-3-26","article-title":"Retrograde transport pathways utilised by viruses and protein toxins","volume":"3","author":"Spooner","year":"2006","journal-title":"Virol. J."},{"key":"2021111608053614400_ETLS-2016-0013CC26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0014-5793(90)80929-D","article-title":"Reduction of adenylyl cyclase activity by cholera toxin in myeloid cells. Long-term down-regulation of Gs alpha subunits by cholera toxin treatment","volume":"267","author":"Hermouet","year":"1990","journal-title":"FEBS Lett."},{"key":"2021111608053614400_ETLS-2016-0013CC27","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1128\/AAC.00122-13","article-title":"Role of 6-gingerol in reduction of cholera toxin activity in vitro and in vivo","volume":"57","author":"Saha","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111608053614400_ETLS-2016-0013CC28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073390","article-title":"Grape extracts inhibit multiple events in the cell biology of cholera intoxication","volume":"8","author":"Reddy","year":"2013","journal-title":"PLoS ONE"},{"key":"2021111608053614400_ETLS-2016-0013CC29","doi-asserted-by":"publisher","first-page":"e0166477","DOI":"10.1371\/journal.pone.0166477","article-title":"Inhibition of cholera toxin and other AB toxins by polyphenolic compounds","volume":"11","author":"Cherubin","year":"2016","journal-title":"PLoS ONE"},{"key":"2021111608053614400_ETLS-2016-0013CC30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2217\/17460913.2.3.335","article-title":"Regulation of virulence in Vibrio cholerae: the ToxR regulon","volume":"2","author":"Childers","year":"2007","journal-title":"Fut. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC31","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1126\/science.272.5270.1910","article-title":"Lysogenic conversion by a filamentous phage encoding cholera toxin","volume":"272","author":"Waldor","year":"1996","journal-title":"Science"},{"key":"2021111608053614400_ETLS-2016-0013CC32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1046\/j.1365-2958.1997.2191585.x","article-title":"A branch in the ToxR regulatory cascade of Vibrio cholerae revealed by characterization of toxT mutant strains","volume":"23","author":"Champion","year":"1997","journal-title":"Mol. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC33","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1128\/AAC.01029-15","article-title":"Conjugated linoleic acid reduces cholera toxin production in vitro and in vivo by inhibiting Vibrio cholerae ToxT activity","volume":"59","author":"Withey","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111608053614400_ETLS-2016-0013CC34","doi-asserted-by":"publisher","first-page":"e00403-13","DOI":"10.1128\/mBio.00403-13","article-title":"Small-molecule inhibitors of toxT expression in Vibrio cholerae","volume":"4","author":"Anthouard","year":"2013","journal-title":"mBio."},{"key":"2021111608053614400_ETLS-2016-0013CC35","doi-asserted-by":"publisher","first-page":"e0137529","DOI":"10.1371\/journal.pone.0137529","article-title":"Suppression of virulence of toxigenic Vibrio cholerae by anethole through the cyclic AMP (cAMP)-cAMP receptor protein signaling system","volume":"10","author":"Zahid","year":"2015","journal-title":"PLoS ONE"},{"key":"2021111608053614400_ETLS-2016-0013CC36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrmicro2688","article-title":"The myriad roles of cyclic AMP in microbial pathogens: from signal to sword","volume":"10","author":"McDonough","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0196-9781(94)00017-Z","article-title":"Bioactive cyclic dipeptides","volume":"16","author":"Prasad","year":"1995","journal-title":"Peptides"},{"key":"2021111608053614400_ETLS-2016-0013CC38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.molmed.2014.08.003","article-title":"Cyclic dipeptides: from bugs to brain","volume":"20","author":"Bellezza","year":"2014","journal-title":"Trends Mol. Med."},{"key":"2021111608053614400_ETLS-2016-0013CC39","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1128\/JB.00191-10","article-title":"The cyclic dipeptide cyclo(Phe-Pro) inhibits cholera toxin and toxin-coregulated pilus production in O1 El Tor Vibrio cholerae","volume":"192","author":"Bina","year":"2010","journal-title":"J. Bacteriol."},{"key":"2021111608053614400_ETLS-2016-0013CC40","doi-asserted-by":"publisher","first-page":"e00366-13","DOI":"10.1128\/mBio.00366-13","article-title":"Vibrio cholerae ToxR downregulates virulence factor production in response to cyclo(Phe-Pro)","volume":"4","author":"Bina","year":"2013","journal-title":"mBio"},{"key":"2021111608053614400_ETLS-2016-0013CC41","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1099\/mic.0.077297-0","article-title":"Cyclo(valine-valine) inhibits Vibrio cholerae virulence gene expression","volume":"160","author":"Vikram","year":"2014","journal-title":"Microbiology"},{"key":"2021111608053614400_ETLS-2016-0013CC42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fcimb.2012.00090","article-title":"Enterohemorrhagic, E. coli (EHEC) pathogenesis","volume":"2","author":"Nguyen","year":"2012","journal-title":"Front. Cell Infect. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrmicro2279","article-title":"Shiga toxins \u2014 from cell biology to biomedical applications","volume":"8","author":"Johannes","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/toxins3060608","article-title":"Shiga toxin: expression, distribution, and its role in the environment","volume":"3","author":"Mauro","year":"2011","journal-title":"Toxins"},{"key":"2021111608053614400_ETLS-2016-0013CC45","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.febslet.2009.11.089","article-title":"Globotriaosyl ceramide receptor function \u2014 where membrane structure and pathology intersect","volume":"584","author":"Lingwood","year":"2010","journal-title":"FEBS Lett."},{"key":"2021111608053614400_ETLS-2016-0013CC46","doi-asserted-by":"publisher","first-page":"e32393","DOI":"10.1371\/journal.pone.0032393","article-title":"Characterizing RecA-independent induction of Shiga toxin 2-encoding phages by EDTA treatment","volume":"7","author":"Imamovic","year":"2012","journal-title":"PLoS ONE"},{"key":"2021111608053614400_ETLS-2016-0013CC47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/mpat.1999.0279","article-title":"Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens","volume":"27","author":"Fuchs","year":"1999","journal-title":"Microb. Pathog."},{"key":"2021111608053614400_ETLS-2016-0013CC48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0092-8674(81)90251-8","article-title":"Induction of SOS functions: regulation of proteolytic activity of, E. coli RecA protein by interaction with DNA and nucleoside triphosphate","volume":"25","author":"Phizicky","year":"1981","journal-title":"Cell"},{"key":"2021111608053614400_ETLS-2016-0013CC49","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1128\/AAC.06315-11","article-title":"Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain","volume":"56","author":"Bielaszewska","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111608053614400_ETLS-2016-0013CC50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/35001095","article-title":"Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands","volume":"403","author":"Kitov","year":"2000","journal-title":"Nature"},{"key":"2021111608053614400_ETLS-2016-0013CC51","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","article-title":"Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial","volume":"290","author":"Trachtman","year":"2003","journal-title":"JAMA"},{"key":"2021111608053614400_ETLS-2016-0013CC52","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1086\/381124","article-title":"Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections","volume":"189","author":"Watanabe","year":"2004","journal-title":"J. Infect. Dis."},{"key":"2021111608053614400_ETLS-2016-0013CC53","doi-asserted-by":"publisher","first-page":"21837","DOI":"10.1038\/srep21837","article-title":"A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"2021111608053614400_ETLS-2016-0013CC54","doi-asserted-by":"publisher","first-page":"7054","DOI":"10.1128\/AAC.01416-15","article-title":"Baicalin inhibits the lethality of Shiga-like toxin 2 in mice","volume":"59","author":"Dong","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111608053614400_ETLS-2016-0013CC55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2010.01.043","article-title":"Inhibition of retrograde transport protects mice from lethal ricin challenge","volume":"141","author":"Stechmann","year":"2010","journal-title":"Cell"},{"key":"2021111608053614400_ETLS-2016-0013CC56","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1128\/AAC.00455-15","article-title":"Retrograde trafficking inhibitor of Shiga toxins reduces morbidity and mortality of mice infected with enterohemorrhagic Escherichia coli","volume":"59","author":"Secher","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111608053614400_ETLS-2016-0013CC57","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1215930","article-title":"Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis","volume":"335","author":"Linstedt","year":"2012","journal-title":"Science"},{"key":"2021111608053614400_ETLS-2016-0013CC58","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2217\/fmb.16.16","article-title":"Selenium reduces enterohemorrhagic Escherichia coli O157:H7 verotoxin production and globotriaosylceramide receptor expression on host cells","volume":"11","author":"Surendran-Nair","year":"2016","journal-title":"Fut. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC59","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1128\/IAI.01099-10","article-title":"Virulence inhibition by zinc in Shiga-toxigenic Escherichia coli","volume":"79","author":"Crane","year":"2011","journal-title":"Infect. Immun."},{"key":"2021111608053614400_ETLS-2016-0013CC60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2180-14-145","article-title":"Zinc protects against Shiga-toxigenic Escherichia coli by acting on host tissues as well as on bacteria","volume":"14","author":"Crane","year":"2014","journal-title":"BMC Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC61","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3389\/fmicb.2016.01930","article-title":"Identification and characterization of novel compounds blocking Shiga toxin expression in Escherichia coli O157:H7","volume":"7","author":"Huerta-Uribe","year":"2016","journal-title":"Front. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC62","doi-asserted-by":"publisher","first-page":"e54456","DOI":"10.1371\/journal.pone.0054456","article-title":"A family of indoles regulate virulence and Shiga toxin production in pathogenic, E. coli","volume":"8,","author":"Bommarius","year":"2013","journal-title":"PLoS ONE"},{"key":"2021111608053614400_ETLS-2016-0013CC63","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.tim.2015.08.001","article-title":"Roles of indole as an interspecies and interkingdom signaling molecule","volume":"23","author":"Lee","year":"2015","journal-title":"Trends Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC64","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1016\/j.tet.2014.05.089","article-title":"Controlling bacterial behavior with indole-containing natural products and derivatives","volume":"70","author":"Melander","year":"2014","journal-title":"Tetrahedron"},{"key":"2021111608053614400_ETLS-2016-0013CC65","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12275-015-5273-3","article-title":"Indole: a signaling molecule or a mere metabolic byproduct that alters bacterial physiology at a high concentration?","volume":"53","author":"Kim","year":"2015","journal-title":"J. Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC66","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.phymed.2014.04.008","article-title":"Coumarins reduce biofilm formation and the virulence of Escherichia coli O157:H7","volume":"21","author":"Lee","year":"2014","journal-title":"Phytomedicine"},{"key":"2021111608053614400_ETLS-2016-0013CC67","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1128\/AAC.02515-13","article-title":"Phenethyl isothiocyanate inhibits Shiga toxin production in enterohemorrhagic Escherichia coli by stringent response induction","volume":"58","author":"Nowicki","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021111608053614400_ETLS-2016-0013CC68","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tim.2013.01.002","article-title":"Bacterial lifestyle shapes stringent response activation","volume":"21","author":"Boutte","year":"2013","journal-title":"Trends Microbiol."},{"key":"2021111608053614400_ETLS-2016-0013CC69","doi-asserted-by":"publisher","first-page":"22263","DOI":"10.1038\/srep22263","article-title":"Isothiocyanates as effective agents against enterohemorrhagic Escherichia coli: insight to the mode of action","volume":"6","author":"Nowicki","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Emerging Topics in Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/emergtoplifesci\/article-pdf\/1\/1\/31\/449798\/etls-2016-0013c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/emergtoplifesci\/article-pdf\/1\/1\/31\/449798\/etls-2016-0013c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T08:05:45Z","timestamp":1637049945000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/emergtoplifesci\/article\/1\/1\/31\/12758\/Disarming-the-enemy-targeting-bacterial-toxins"}},"subtitle":[],"editor":[{"given":"Daniel","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,4,21]]},"published-print":{"date-parts":[[2017,4,21]]}},"URL":"https:\/\/doi.org\/10.1042\/etls20160013","relation":{},"ISSN":["2397-8554","2397-8562"],"issn-type":[{"value":"2397-8554","type":"print"},{"value":"2397-8562","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}